Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 1;50(22):5324-9.
doi: 10.1021/jm070683u. Epub 2007 Oct 6.

From docking false-positive to active anti-HIV agent

Affiliations

From docking false-positive to active anti-HIV agent

Gabriela Barreiro et al. J Med Chem. .

Abstract

Virtual screening of the Maybridge library of ca. 70 000 compounds was performed using a similarity filter, docking, and molecular mechanics-generalized Born/surface area postprocessing to seek potential non-nucleoside inhibitors of human immunodeficiency virus-1 (HIV-1) reverse transcriptase (NNRTIs). Although known NNRTIs were retrieved well, purchase and assaying of representative, top-scoring compounds from the library failed to yield any active anti-HIV agents. However, the highest-ranked library compound, oxadiazole 1, was pursued as a potential "near-miss" with the BOMB program to seek constructive modifications. Subsequent synthesis and assaying of several polychloro-analogs did yield anti-HIV agents with EC50 values as low as 310 nM. The study demonstrates that it is possible to learn from a formally unsuccessful virtual-screening exercise and, with the aid of computational analyses, to efficiently evolve a false positive into a true active.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Computed structure for 1 bound to HIV-1 reverse transcriptase from Glide docking followed by energy minimization with MacroModel. Only protein residues in the first layer around the ligand are illustrated. The ligand is positioned as expected from known structures such as for 4.,
Figure 2
Figure 2
Training results for scoring using BOMB for 339 complexes with HIV-RT (magenta – uracil derivatives, green – analogs of 2), COX-2 (blue), FKBP (red), and p38 kinase (black). The correlation coefficient for the fit, r2, is 0.58 and the rms error is 0.82 log unit. Indicator variables are used to provide constant offsets for three datasets.
Figure 3
Figure 3
Structure for the complex of 1 with HIV-RT as computed by BOMB. The 176 residues nearest the ligand are included in the calculations.
Scheme 1
Scheme 1
Recent NNRTI Hits from HTS (Reference 12)
Scheme 2
Scheme 2
Synthesis of 2,5-oxadiazole derivatives.

Similar articles

Cited by

References

    1. 2006 AIDS Epidemic Update. Geneva: UNAIDS; 2006.
    1. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 1992;256:1783–1790. - PubMed
    2. Smerdon SJ, Jäger J, Wang J, Kohlstaedt LA, Chirino AJ, Friedman JM, Rice PA, Steitz TA. Structure of the binding site for nonnucleoside inhibitors of reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 1994;91:3911–3915. - PMC - PubMed
    3. De Clercq E. New approaches toward anti-HIV chemotherapy. J. Med. Chem. 2005;48:1297–1313. - PubMed
    1. Jorgensen WL, Ruiz-Caro J, Tirado-Rives J, Basavapathruni A, Anderson KS, Hamilton AD. Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett. 2006;16:663–667. - PubMed
    2. Ruiz-Caro J, Basavapathruni A, Kim JT, Wang L, Bailey CM, Anderson KS, Hamilton AD, Jorgensen WL. Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett. 2006;16:668–671. - PubMed
    3. Thakur VV, Kim JT, Hamilton AD, Bailey CM, Domaoal RA, Wang L, Anderson KS, Jorgensen WL. Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett. 2006;16:5664–5667. - PubMed
    4. Kim JT, Hamilton AD, Bailey CM, Domaoal RA, Wang L, Anderson KS, Jorgensen WL. FEP-guided selection of bicyclic heterocycles in lead optimization for non-nucleoside inhibitors of HIV-1 reverse transcriptase. J. Am. Chem. Soc. 2006;128:15372–15373. - PubMed
    1. Blake JF, Laird ER. Recent advances in virtual ligand screening. Ann. Rep. Med. Chem. 2003;38:305–314.
    2. Leach AR, Shoichet BK, Peishoff CE. Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. J. Med. Chem. 2006;49:5851–5855. - PubMed
    1. Barreiro G, Guimarães CRW, Tubert-Brohman I, Lyons TM, Tirado-Rives J, Jorgensen WL. Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring. J. Chem. Info. Model. 2007 in press. - PMC - PubMed

Publication types

MeSH terms